Healthcare research from Johnson & Johnson, page 7
A filtered view. Show the full list.
Refine
Listings
-
ReviewProstate cancer and prostatic diseases
Navigating drug-drug interactions with apalutamide
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleNature communications
Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
NeuroscienceAdded
-
ArticleNature communications
Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleNPJ vaccines
Safety, immunogenicity, and baseline immune correlates of vaccine JNJ-0535 in participants with or without CHB
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleNature medicine
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
Clinical trial reportNature medicine
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportNature medicine
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewNature methods
Recommendations and considerations for hydroxyl radical protein footprinting-mass spectrometry
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleNature computational science
Robust out-of-distribution prediction of Buchwald-Hartwig reactions
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Other scienceAdded
-
ArticleCommunications medicine
Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleChemical communications (Cambridge, England)
High-throughput chiral analysis using automated desorption electrospray ionization mass spectrometry
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Other scienceAdded
-
LetterGastroenterology
Reply
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Other scienceAdded
-
ArticleAmerican journal of perinatology
Plain Language Summary of Publication: Design of the Phase 3 FREESIA-1 and FREESIA-3 Trials of Nipocalimab in Fetal and Neonatal Alloimmune Thrombocytopenia
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewAmerican journal of perinatology
The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit-Risk, Autonomy, and Maternal-Fetal Interests
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleAmerican journal of perinatology
Plain Language Summary of Publication: Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ArticleAmerican journal of perinatology
Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ArticleNEJM evidence
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
LetterThe New England journal of medicine
Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. Reply
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providers
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Johnson & Johnson, with Temple Health linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Retrospective study of visual acuity changes in patients with interstitial cystitis receiving pentosan polysulfate sodium
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded